Sarcopenia in long‐term survivors of cancer in childhood and adolescence: A cross‐sectional study of calf muscle mass by peripheral quantitative computed tomography with an examination of the muscle–bone unit
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.30705 ↗At a glance
Journal article in Pediatric Blood & Cancer, 2024. Written by Louise Guolla and 4 co-authors. Institution: Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada. Major MEDLINE topics: Sarcopenia, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Cited 11 times so far (Crossref); 62 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: CIHR, Canadian Institutes of Health Research.
Abstract (original language)
Background
Sarcopenia, a loss of systemic skeletal muscle mass (SMM), is prevalent in childhood cancer survivors and often accompanied by increased fat mass (sarcopenic obesity [SO]). We examined whether calf muscle cross‐sectional area (CSA), measured by peripheral quantitative computed tomography (pQCT), can identify sarcopenia and SO in long‐term survivors of pediatric acute lymphoblastic leukemia (ALL), and explored its relationship with adjacent bone geometry. Procedures Calf muscle CSA and CSA Z scores at the 38% tibia in 70 subjects (median survival 15 years) were compared between sexes and ALL risk group, and their association with sarcopenia and SO evaluated. Relationships between bone strength and muscle mass were assessed further using linear regression and methods described by Schoenau et al. for evaluation of a functional muscle–bone unit.
Results
A calf muscle CSA Z score of less than or equal to zero is 73.81% sensitive and 84.62% specific for detecting sarcopenia defined by height‐adjusted appendicular lean mass measured by dual‐energy x‐ray absorptiometry. No significant difference in CSA Z scores was noted between sexes or ALL risk groups; however, Z scores were markedly higher in those without SO (adjusted odds ratio 0.529, 95% confidence interval [CI]: 0.340–0.824). Ratios of calf muscle mass to height and total bone mineral content at the 38% tibia are “sufficient” and consistent with estimated reference ranges for a healthy population.
Conclusions
CSA Z scores may represent a useful clinical measure of SMM and are predictive of SO in this population. Our results are supportive of a functional muscle–bone unit in long‐term survivors of pediatric ALL.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
- Department of Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada.
- Department of Biochemistry, RadioImmunology and Experimental Medicine, The Children's Memorial Health Institute, Warsaw, Poland.
- Departments of Nuclear Medicine and Radiology, McMaster University, Hamilton, Ontario, Canada.
- Department of Nuclear Medicine, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada.
ORCID profiles: Louise Guolla, Ronald Barr
Funding
- CIHR
- Canadian Institutes of Health Research
Cite
APA
Guolla, L., Barr, R., Jaworski, M., Farncombe, T., & Gordon, C. (2024). Sarcopenia in long‐term survivors of cancer in childhood and adolescence: A cross‐sectional study of calf muscle mass by peripheral quantitative computed tomography with an examination of the muscle–bone unit. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30705
Vancouver
Guolla L, Barr R, Jaworski M, Farncombe T, Gordon C. Sarcopenia in long‐term survivors of cancer in childhood and adolescence: A cross‐sectional study of calf muscle mass by peripheral quantitative computed tomography with an examination of the muscle–bone unit. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30705
BibTeX
@article{Guolla2024,
author = {Guolla, Louise and Barr, Ronald and Jaworski, Maciej and Farncombe, Troy and Gordon, Christopher},
title = {Sarcopenia in long‐term survivors of cancer in childhood and adolescence: A cross‐sectional study of calf muscle mass by peripheral quantitative computed tomography with an examination of the muscle–bone unit},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.30705}
}
EUVIMED